Lymphocyte Function Alteration [PE] - N0000178327

Name: Table of NDC products with lymphocyte function alteration
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000178327
Pharmacologic Name	Lymphocyte Function Alteration
Pharmacologic Uses	immunoglobulin G
Pharmacologic Concept	Physiologic Effects - [PE]
Pharmacologic Concept Description	This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Lymphocyte Function Alteration

The table contains 5 products whose active ingredient are classified under the same pharmacologic class Lymphocyte Function Alteration [PE].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0009-7224	Atgam	Non-Proprietary Name: Equine Thymocyte Immune Globulin	Injection, Solution	Intravenous	Pharmacia & Upjohn Company Llc	ACTIVE
48951-6050	Lymphocytes 8	Non-Proprietary Name: Lymphocytes 8	Liquid	Oral	Uriel Pharmacy Inc.	ACTIVE
48951-6060	Lymphocytes 30 Special Order	Non-Proprietary Name: Lymphocytes 30 Special Order	Liquid	Oral	Uriel Pharmacy Inc.	ACTIVE
48951-6080	Lymphocytes 6x	Non-Proprietary Name: Lymphocytes 6x	Liquid	Oral	Uriel Pharmacy Inc.	ACTIVE
58468-0080	Thymoglobulin	Non-Proprietary Name: Anti-thymocyte Globulin (rabbit)	Injection, Powder, Lyophilized, For Solution	Intravenous	Genzyme Corporation	ACTIVE